| Trial name or title |
CBT as an Adjunct to SRIs in the Treatment of BDD |
| Methods |
Randomized, Double‐Blind, Active Control, Parallel Assignment, Efficacy Study |
| Participants |
20 DSM‐IV BDD patients aged 16 through 65. Score of 20 or greater on the BDD‐YBOCS, on a stable, therapeutic does of an SRI (at least 12 weeks on the SRI with 8 weeks at a therapeutic dose: acceptable medications (therapeutic daily doses) are citalopram (40mg), clomipramine (150mg), fluoxetine (40mg), fluvoxamine (150mg), paroxetine (40mg), sertraline (50mg), and venlafaxine (150mg). |
| Interventions |
CBT versus relaxation and stress management training (RSMT); augmentation of SRIs |
| Outcomes |
BDD‐YBOCS, BDD‐CGI, BABS, BDI‐II, BAI |
| Starting date |
No information |
| Contact information |
Bryann Baker, tel: (212) 492‐9449, bryann.baker@mssm.edu |
| Notes |
Study ID numbers: GCO 00‐0211PS* |
